Skip to main content
. Author manuscript; available in PMC: 2023 Jan 12.
Published in final edited form as: Stat Sin. 2022;32:1983–2005. doi: 10.5705/ss.202020.0248

Table 4:

Experimentation and percentage of trials recommending at least a dose in sets H1 = {(2, 3), (3, 3)}, H2 = {(3, 2),(3, 3)}, H3 = {(4, 1)} and H4 = {(1, 4)} for poSPMc, poSPM1 and poSPM2. Each of this set may be the only one containing dose combitions sufficiently efficacious and not associated with overly toxicity probabilities.

Experimentation %
Scenario T Method H 1 H 2 H 3 H 4
poSPMc 18.8 16.7 10.6 8.0
poSPM1 32.6 37.2 4.3 2.9
poSPM2 12.6 24.5 0.1 17.8
% of trials Recommendation
Scenario T Method H 1 H 2 H 3 H 4
poSPMc 65.2 74.3 64.8 62.8
poSPM1 44.9 43.6 6.5 3.75
poSPM2 21.3 41.3 0.2 20.2